Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - Target Group Inc.tv502725_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Target Group Inc.tv502725_ex99-1.htm
8-K/A - FORM 8-K/A - Target Group Inc.tv502725_8ka.htm

 

Exhibit 23.1

 

 

802 N Washington

Spokane, WA 99201

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 


We consent to the incorporation by reference of our audit report dated September 12, 2018 relating to the financial statements of Canary RX, Inc., appearing in this Current Report on Form 8-K dated September 12, 2018, for the years ended December 31, 2017 and 2016. Our report dated September 12, 2018, with respect to those financial statements, includes an emphasis of matter paragraph relating to the uncertainty of Canary RX, Inc.’s ability to continue as a going concern.

 

 

 

Fruci & Associates II, PLLC

 

Spokane, Washington

 

September 12, 2018